Global Nuclear Medicine Imaging Agents Market Growth 2023-2029

Global Nuclear Medicine Imaging Agents Market Growth 2023-2029

The global Nuclear Medicine Imaging Agents market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Nuclear Medicine Imaging Agents is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Nuclear Medicine Imaging Agents is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Nuclear Medicine Imaging Agents is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Nuclear Medicine Imaging Agents players cover GE HealthCare, Bracco Diagnostic, Guerbet, Mallinckrodt, Lantheus, Yantai Dongcheng, Foshan Rui Diao Pharmaceutical, Cardinal Health and Blue Earth Diagnostics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

LPI (LP Information)' newest research report, the “Nuclear Medicine Imaging Agents Industry Forecast” looks at past sales and reviews total world Nuclear Medicine Imaging Agents sales in 2022, providing a comprehensive analysis by region and market sector of projected Nuclear Medicine Imaging Agents sales for 2023 through 2029. With Nuclear Medicine Imaging Agents sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nuclear Medicine Imaging Agents industry.

This Insight Report provides a comprehensive analysis of the global Nuclear Medicine Imaging Agents landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Nuclear Medicine Imaging Agents portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Nuclear Medicine Imaging Agents market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nuclear Medicine Imaging Agents and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nuclear Medicine Imaging Agents.

This report presents a comprehensive overview, market shares, and growth opportunities of Nuclear Medicine Imaging Agents market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Fluorine 18 Labeling
Carbon 11 Labeling
Nitrogen 13 Labeling
Oxygen 15 Labeling
Technetium 99 Labeling
Others

Segmentation by application
Early Diagnosis
Clinical Stage
Treatment Evaluation

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
GE HealthCare
Bracco Diagnostic
Guerbet
Mallinckrodt
Lantheus
Yantai Dongcheng
Foshan Rui Diao Pharmaceutical
Cardinal Health
Blue Earth Diagnostics
Bayer AG
Abx Advanced Biochemical
Eli Lilly and Company
Jubilant Pharma Limited
Navidea

Key Questions Addressed in this Report

What is the 10-year outlook for the global Nuclear Medicine Imaging Agents market?

What factors are driving Nuclear Medicine Imaging Agents market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Nuclear Medicine Imaging Agents market opportunities vary by end market size?

How does Nuclear Medicine Imaging Agents break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.